ETF Financing Ranking | GF Fund CSI HK Connect Financials(ex Banks) Thematic ETF (513750) had a net financing buy-in of CNY 243.22 million, ranked in the top 2 in the entire market-20260622
NewTimeSpace (newtimespace.com) News,Jun 22, 2026, GF Fund CSI HK Connect Financials(ex Banks) Thematic ETF (513750.SH) had a net financing buy-in of CNY 243.22 million, ranked in the top 2 in the entire market.
NewTimeSpace (newtimespace.com) News,Jun 22, 2026, GF Fund CSI HK Connect Financials(ex Banks) Thematic ETF (513750.SH) increased by 3.84%, had a turnover of CNY 2.34 billion. Obtained financing buy-in of CNY 361.03 million, and financing repayment of CNY 117.81 million, with a net financing buy-in of CNY 243.22 million, ranked in the top 2 in the entire market. (Data source: Wind)
GF Fund CSI HK Connect Financials(ex Banks) Thematic ETF (513750.SH), off-exchange connection (A type: 020500; C type: 020501).
NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
Tags:
- ETF Financing Ranking | GF Fund CSI HK Connect Financials(ex Banks) Thematic ETF (513750) had a net financing buy-in of CNY 20.32 million on Sep 10
- ETF Financing Ranking | GF Fund CSI HK Connect Financials(ex Banks) Thematic ETF (513750) had a net financing buy-in of CNY 14.3 million Sep 8
- Implementation of the Pharmaceutical Industry Development “15th Five-Year Plan” and Standout Data for Domestic Novel Drugs at WCLC: Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) Rose 10.82%
- ZHIZU IOT: CSRC seeks supplementary materials on shareholder rights, export control
- YZYBIO-B (02496.HK): Proposes Issuing 35.59 Million Domestic Shares to Three Directors at RMB 2.43 Each, Raising about RMB 83 Million; Whitewash Waiver Sought and Trading to Resume